According to Gram Research analysis, specific gut bacteria patterns can predict which Crohn’s disease patients will benefit from the CDED exclusion diet. A 2026 randomized controlled trial found that patients whose baseline microbiome contained higher levels of Alistipes and Faecalibacterium bacteria, and lower levels of Haemophilus and Prevotella, were significantly more likely to achieve sustained symptom relief after 24 weeks on the diet. When the diet worked, patients’ gut bacteria shifted to resemble healthy children’s microbiomes, suggesting a potential biomarker for personalizing Crohn’s treatment.
Researchers studied how a special eating plan called the Crohn’s disease exclusion diet (CDED) changes the bacteria in your gut and whether those changes predict who will feel better. They found that people whose gut bacteria shifted in specific ways—with more of certain helpful bacteria and fewer harmful ones—were much more likely to experience lasting relief from their symptoms. The study compared adults and children with Crohn’s disease to healthy children, discovering that successful treatment actually made sick people’s gut bacteria look more like healthy people’s bacteria. This suggests doctors might one day use a simple gut bacteria test to figure out which patients will benefit most from this dietary approach.
Key Statistics
A 2026 randomized controlled trial published in Crohn’s & Colitis 360 found that patients with sustained clinical remission on the CDED diet had distinctly different baseline gut bacteria composition, with higher relative abundances of Alistipes and Faecalibacterium bacteria compared to those whose symptoms didn’t improve.
According to the same 2026 study, successful CDED treatment was associated with lower overall bacterial diversity and enrichment of genes for redox balance, fatty acid metabolism, and DNA repair, while unsuccessful treatment showed elevated pro-inflammatory bacterial pathways.
The research demonstrated that when the CDED diet induced remission in adults with Crohn’s disease, their microbiome composition shifted toward a profile more similar to healthy pediatric controls, suggesting dietary therapy normalizes the gut bacterial community.
The Quick Take
- What they studied: Whether changes in gut bacteria during a special Crohn’s disease diet could predict which patients would feel better and stay better long-term
- Who participated: Adults with mild-to-moderate Crohn’s disease and children with Crohn’s disease, compared to healthy children without the disease
- Key finding: People whose gut bacteria shifted toward having more Alistipes and Faecalibacterium bacteria, and less Haemophilus and Prevotella, were significantly more likely to achieve lasting symptom relief after 12 and 24 weeks on the CDED diet
- What it means for you: A gut bacteria test before starting the CDED diet might help doctors predict whether this dietary approach will work for you, allowing for more personalized treatment planning. However, this is still research—talk to your doctor before making major dietary changes for Crohn’s disease management
The Research Details
This was a randomized controlled trial, which is one of the strongest types of medical research. Researchers tracked the gut bacteria of adults with Crohn’s disease at the start of the study, then again after 6 weeks, 12 weeks, and 24 weeks on the CDED diet. They also studied children with Crohn’s disease and compared both groups to healthy children who didn’t have the disease.
The researchers used advanced genetic testing to identify which bacteria were present in each person’s gut and in what amounts. They also analyzed the genes that these bacteria carried, looking at what functions those genes performed—essentially understanding what the bacteria were “doing” in the gut.
They then compared the gut bacteria of people who felt significantly better and stayed better (called sustained clinical remission) with those whose symptoms didn’t improve. This allowed them to identify specific bacterial patterns that seemed to predict success with the diet.
Understanding which gut bacteria changes predict success is important because Crohn’s disease is unpredictable—the same treatment doesn’t work for everyone. If doctors could identify ahead of time which patients will benefit from the CDED diet based on their baseline gut bacteria, they could avoid wasting time on treatments unlikely to help and focus on more effective options for each individual patient. This represents a shift toward personalized medicine.
This study used a randomized controlled trial design, which is considered high-quality evidence. The researchers tracked participants over 24 weeks and used advanced genetic sequencing to analyze the microbiome, which is more accurate than older methods. However, the exact number of participants wasn’t specified in the abstract, which makes it harder to assess how broadly these findings might apply. The study compared adults to children, which strengthens the findings by showing patterns across age groups.
What the Results Show
The most important finding was that people who achieved sustained clinical remission (meaning their symptoms improved significantly and stayed improved) had distinctly different gut bacteria at the start of the study compared to those whose symptoms didn’t improve. Specifically, successful patients had lower overall bacterial diversity—meaning fewer different types of bacteria, but the bacteria present were more beneficial.
The bacteria that predicted success included Alistipes and Faecalibacterium, which are considered “good” bacteria that help maintain a healthy gut. In contrast, patients whose symptoms didn’t improve had higher levels of Haemophilus and Prevotella bacteria, which are associated with inflammation.
Beyond just counting bacteria, the researchers looked at the genes these bacteria carried. Successful patients had bacteria with genes involved in maintaining balance in the gut environment, breaking down fats for energy, and repairing DNA damage. Unsuccessful patients had bacteria with genes related to bacterial stickiness (adhesion), which helps bacteria attach to the gut wall and cause inflammation, and genes involved in inflammatory pathways.
Perhaps most remarkably, when the CDED diet worked, the gut bacteria of adults with Crohn’s disease actually shifted to look more similar to the gut bacteria of healthy children—suggesting the diet was essentially “normalizing” their microbiome.
The study found that baseline microbial composition—meaning what bacteria were present before starting the diet—was different between those who would succeed and those who wouldn’t. This suggests that a simple test at the beginning could potentially predict outcomes. The research also showed that functional potential (what the bacteria could do based on their genes) was just as important as which bacteria were present, indicating that understanding bacterial function, not just identity, matters for predicting success.
Previous research has shown that the CDED diet can help some Crohn’s patients achieve remission, but this is the first detailed study examining how gut bacteria changes predict who will benefit. This research builds on earlier findings by providing a biological mechanism—specific bacterial and genetic changes—that explains why the diet works for some people. It also extends previous work by comparing adults and children, showing that these bacterial patterns appear consistent across age groups.
The study abstract doesn’t specify the exact number of participants, making it difficult to assess how reliable the findings are. The study only included patients with mild-to-moderate Crohn’s disease, so results may not apply to people with severe disease. Additionally, while the study identified bacterial patterns associated with success, it doesn’t prove that these bacteria cause the improvement—only that they’re associated with it. More research is needed before doctors can use gut bacteria testing to routinely predict CDED success in clinical practice.
The Bottom Line
If you have mild-to-moderate Crohn’s disease, discuss the CDED diet with your gastroenterologist as a potential treatment option. This research suggests that a gut bacteria test might eventually help predict whether this diet will work for you, but this application isn’t yet standard clinical practice. Don’t start any new diet for Crohn’s disease without medical supervision, as dietary changes can affect medication absorption and symptom management. (Confidence level: Moderate—this is promising research but needs confirmation in larger studies)
People with mild-to-moderate Crohn’s disease and their doctors should find this research interesting, as it offers hope for more personalized treatment planning. Gastroenterologists may eventually use these findings to better counsel patients about whether to try the CDED diet. People with severe Crohn’s disease or other inflammatory bowel conditions should consult their doctor, as this research specifically studied mild-to-moderate disease. Healthy people don’t need to apply these findings.
In the study, changes in gut bacteria and symptom improvement were measured over 24 weeks (about 6 months). If you were to try the CDED diet, you might expect to see initial changes in symptoms within 6 weeks, with fuller benefits by 12 weeks. However, individual responses vary significantly, and some people may not respond at all.
Frequently Asked Questions
Can a gut bacteria test tell me if the Crohn’s disease exclusion diet will work for me?
Not yet in clinical practice, but research is moving in that direction. A 2026 study found that specific baseline bacteria patterns predicted CDED success, but doctors need more research before using this test routinely. Talk to your gastroenterologist about whether you’re a candidate for CDED based on your disease severity and medical history.
What bacteria should I want in my gut if I have Crohn’s disease?
Research shows Alistipes and Faecalibacterium bacteria are associated with better outcomes on the CDED diet, while Haemophilus and Prevotella are linked to continued inflammation. However, your overall bacterial balance matters more than any single type. A healthy microbiome is diverse and personalized to you.
How long does it take for the CDED diet to change your gut bacteria?
In this study, researchers measured changes at 6, 12, and 24 weeks. Most participants showed measurable bacterial shifts by 6-12 weeks, with continued improvement by 24 weeks. Individual timelines vary, so discuss realistic expectations with your doctor.
Does the CDED diet work the same way for adults and children with Crohn’s disease?
This study compared both groups and found similar bacterial patterns predicted success in both adults and children, suggesting the diet’s mechanism is consistent across ages. However, children may have different nutritional needs, so treatment should always be supervised by a pediatric gastroenterologist.
If the CDED diet doesn’t work for me, does that mean my gut bacteria are permanently unhealthy?
No. This research shows that specific baseline bacteria patterns predict CDED success, but it doesn’t mean your microbiome can’t improve with other treatments. Your doctor can explore alternative therapies, medications, or dietary approaches tailored to your individual situation.
Want to Apply This Research?
- If using a health app while on the CDED diet, track weekly symptom severity (pain level 1-10, bowel movement frequency, energy level) alongside dietary adherence percentage. This creates a personal data set to show your doctor whether the diet is working for you specifically.
- Use the app to log meals according to CDED guidelines and set reminders for meal timing. Create a symptom journal that notes what you eat and how you feel 2-4 hours later, helping identify which specific foods trigger your symptoms. This personalized tracking is more useful than general diet advice since the research shows individual responses vary.
- Establish a baseline of your current symptoms before starting any dietary changes. Then track weekly for the first 12 weeks to see if the CDED diet is helping you personally. After 12 weeks, if you’re improving, continue tracking monthly to ensure benefits are sustained. Share this data with your gastroenterologist at appointments to make informed decisions about continuing or adjusting your treatment.
This research is promising but still emerging. The CDED diet and microbiome testing for Crohn’s disease are not yet standard clinical practice. Do not start the CDED diet or make major dietary changes without consulting your gastroenterologist, as dietary modifications can affect medication absorption and disease management. This article summarizes research findings and should not be considered medical advice. Individual responses to dietary therapy vary significantly. Always work with your healthcare team to develop a treatment plan appropriate for your specific condition and medical history.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.